UnitedHealth Group (UNH) Issues FY 2019 Earnings Guidance

UnitedHealth Group (NYSE:UNH) updated its FY 2019 earnings guidance on Tuesday. The company provided EPS guidance of $14.50-14.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $14.65. UnitedHealth Group also updated its FY19 guidance to $14.50-14.75 EPS.

A number of brokerages have recently issued reports on UNH. ValuEngine lowered shares of UnitedHealth Group from a buy rating to a hold rating in a research report on Wednesday, February 27th. Credit Suisse Group restated a buy rating and set a $310.00 target price on shares of UnitedHealth Group in a research report on Friday, February 8th. Oppenheimer raised their target price on shares of UnitedHealth Group from $300.00 to $305.00 and gave the stock an outperform rating in a research report on Wednesday, January 16th. Zacks Investment Research lowered shares of UnitedHealth Group from a buy rating to a hold rating in a research report on Tuesday, March 19th. Finally, Cantor Fitzgerald restated a buy rating and set a $310.00 target price on shares of UnitedHealth Group in a research report on Tuesday, January 15th. One analyst has rated the stock with a sell rating, one has given a hold rating, twenty have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of Buy and a consensus target price of $289.45.

UnitedHealth Group stock opened at $216.84 on Thursday. UnitedHealth Group has a one year low of $208.07 and a one year high of $287.94. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a market capitalization of $220.89 billion, a price-to-earnings ratio of 16.84, a price-to-earnings-growth ratio of 1.18 and a beta of 0.79.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 EPS for the quarter, beating analysts’ consensus estimates of $3.60 by $0.13. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The company had revenue of $60.30 billion during the quarter, compared to the consensus estimate of $59.72 billion. During the same quarter last year, the company earned $3.04 earnings per share. UnitedHealth Group’s quarterly revenue was up 9.2% compared to the same quarter last year. On average, analysts predict that UnitedHealth Group will post 14.63 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 1.66%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 27.95%.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 2,930 shares of the firm’s stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $253.39, for a total value of $742,432.70. Following the completion of the sale, the director now owns 64,726 shares of the company’s stock, valued at $16,400,921.14. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction on Tuesday, March 19th. The shares were sold at an average price of $257.32, for a total value of $1,286,600.00. Following the completion of the sale, the director now directly owns 182,454 shares of the company’s stock, valued at approximately $46,949,063.28. The disclosure for this sale can be found here. In the last three months, insiders sold 17,930 shares of company stock valued at $4,587,133. 0.87% of the stock is owned by corporate insiders.

WARNING: This report was reported by WKRB News and is the sole property of of WKRB News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.wkrb13.com/2019/04/18/unitedhealth-group-unh-issues-fy-2019-earnings-guidance.html.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: Systematic Risk

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.